| Product Code: ETC10600206 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
The India human immunodeficiency virus therapeutics market import shipment demonstrated robust growth with a CAGR of 21.0% from 2020 to 2024. The growth momentum accelerated notably between 2023 and 2024, with a growth rate of 46.7%. The market expanded significantly, indicating a strong upward trend during the period analyzed.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Human Immunodeficiency Virus Therapeutics Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Human Immunodeficiency Virus Therapeutics Market Revenues & Volume, 2021 & 2031F |
3.3 India Human Immunodeficiency Virus Therapeutics Market - Industry Life Cycle |
3.4 India Human Immunodeficiency Virus Therapeutics Market - Porter's Five Forces |
3.5 India Human Immunodeficiency Virus Therapeutics Market Revenues & Volume Share, By Treatment Class, 2021 & 2031F |
3.6 India Human Immunodeficiency Virus Therapeutics Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.7 India Human Immunodeficiency Virus Therapeutics Market Revenues & Volume Share, By Formulation Type, 2021 & 2031F |
3.8 India Human Immunodeficiency Virus Therapeutics Market Revenues & Volume Share, By Target Population, 2021 & 2031F |
3.9 India Human Immunodeficiency Virus Therapeutics Market Revenues & Volume Share, By Therapeutic Area, 2021 & 2031F |
4 India Human Immunodeficiency Virus Therapeutics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of human immunodeficiency virus (HIV) in India |
4.2.2 Growing awareness about HIV/AIDS and available treatment options |
4.2.3 Government initiatives to improve healthcare infrastructure and access to HIV therapeutics |
4.3 Market Restraints |
4.3.1 High cost of HIV therapeutics leading to affordability issues for patients |
4.3.2 Stigma associated with HIV/AIDS leading to underreporting and delayed treatment initiation |
5 India Human Immunodeficiency Virus Therapeutics Market Trends |
6 India Human Immunodeficiency Virus Therapeutics Market, By Types |
6.1 India Human Immunodeficiency Virus Therapeutics Market, By Treatment Class |
6.1.1 Overview and Analysis |
6.1.2 India Human Immunodeficiency Virus Therapeutics Market Revenues & Volume, By Treatment Class, 2021 - 2031F |
6.1.3 India Human Immunodeficiency Virus Therapeutics Market Revenues & Volume, By Antiretrovirals, 2021 - 2031F |
6.1.4 India Human Immunodeficiency Virus Therapeutics Market Revenues & Volume, By Protease Inhibitors, 2021 - 2031F |
6.1.5 India Human Immunodeficiency Virus Therapeutics Market Revenues & Volume, By Integrase Inhibitors, 2021 - 2031F |
6.1.6 India Human Immunodeficiency Virus Therapeutics Market Revenues & Volume, By Reverse Transcriptase Inhibitors, 2021 - 2031F |
6.1.7 India Human Immunodeficiency Virus Therapeutics Market Revenues & Volume, By Entry Inhibitors, 2021 - 2031F |
6.2 India Human Immunodeficiency Virus Therapeutics Market, By Drug Type |
6.2.1 Overview and Analysis |
6.2.2 India Human Immunodeficiency Virus Therapeutics Market Revenues & Volume, By Inhibitors, 2021 - 2031F |
6.2.3 India Human Immunodeficiency Virus Therapeutics Market Revenues & Volume, By Combination Therapy, 2021 - 2031F |
6.2.4 India Human Immunodeficiency Virus Therapeutics Market Revenues & Volume, By Single Tablet Regimen, 2021 - 2031F |
6.2.5 India Human Immunodeficiency Virus Therapeutics Market Revenues & Volume, By Fixed-dose Combinations, 2021 - 2031F |
6.2.6 India Human Immunodeficiency Virus Therapeutics Market Revenues & Volume, By Injectable, 2021 - 2031F |
6.3 India Human Immunodeficiency Virus Therapeutics Market, By Formulation Type |
6.3.1 Overview and Analysis |
6.3.2 India Human Immunodeficiency Virus Therapeutics Market Revenues & Volume, By Oral, 2021 - 2031F |
6.3.3 India Human Immunodeficiency Virus Therapeutics Market Revenues & Volume, By Injectable, 2021 - 2031F |
6.3.4 India Human Immunodeficiency Virus Therapeutics Market Revenues & Volume, By Injectable/Oral, 2021 - 2031F |
6.3.5 India Human Immunodeficiency Virus Therapeutics Market Revenues & Volume, By Oral, 2021 - 2031F |
6.3.6 India Human Immunodeficiency Virus Therapeutics Market Revenues & Volume, By Subcutaneous, 2021 - 2031F |
6.4 India Human Immunodeficiency Virus Therapeutics Market, By Target Population |
6.4.1 Overview and Analysis |
6.4.2 India Human Immunodeficiency Virus Therapeutics Market Revenues & Volume, By Adults, 2021 - 2031F |
6.4.3 India Human Immunodeficiency Virus Therapeutics Market Revenues & Volume, By Children, 2021 - 2031F |
6.4.4 India Human Immunodeficiency Virus Therapeutics Market Revenues & Volume, By At-Risk Populations, 2021 - 2031F |
6.4.5 India Human Immunodeficiency Virus Therapeutics Market Revenues & Volume, By Patients with Low CD4 Count, 2021 - 2031F |
6.4.6 India Human Immunodeficiency Virus Therapeutics Market Revenues & Volume, By HIV-Positive Patients, 2021 - 2031F |
6.5 India Human Immunodeficiency Virus Therapeutics Market, By Therapeutic Area |
6.5.1 Overview and Analysis |
6.5.2 India Human Immunodeficiency Virus Therapeutics Market Revenues & Volume, By HIV/AIDS Treatment, 2021 - 2031F |
6.5.3 India Human Immunodeficiency Virus Therapeutics Market Revenues & Volume, By HIV Prevention, 2021 - 2031F |
6.5.4 India Human Immunodeficiency Virus Therapeutics Market Revenues & Volume, By Viral Suppression, 2021 - 2031F |
6.5.5 India Human Immunodeficiency Virus Therapeutics Market Revenues & Volume, By Early Intervention, 2021 - 2031F |
6.5.6 India Human Immunodeficiency Virus Therapeutics Market Revenues & Volume, By Prevention and Treatment, 2021 - 2031F |
7 India Human Immunodeficiency Virus Therapeutics Market Import-Export Trade Statistics |
7.1 India Human Immunodeficiency Virus Therapeutics Market Export to Major Countries |
7.2 India Human Immunodeficiency Virus Therapeutics Market Imports from Major Countries |
8 India Human Immunodeficiency Virus Therapeutics Market Key Performance Indicators |
8.1 Number of individuals accessing HIV testing and counseling services |
8.2 Percentage of HIV-positive individuals on antiretroviral therapy (ART) |
8.3 Rate of viral load suppression among HIV patients on treatment |
9 India Human Immunodeficiency Virus Therapeutics Market - Opportunity Assessment |
9.1 India Human Immunodeficiency Virus Therapeutics Market Opportunity Assessment, By Treatment Class, 2021 & 2031F |
9.2 India Human Immunodeficiency Virus Therapeutics Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.3 India Human Immunodeficiency Virus Therapeutics Market Opportunity Assessment, By Formulation Type, 2021 & 2031F |
9.4 India Human Immunodeficiency Virus Therapeutics Market Opportunity Assessment, By Target Population, 2021 & 2031F |
9.5 India Human Immunodeficiency Virus Therapeutics Market Opportunity Assessment, By Therapeutic Area, 2021 & 2031F |
10 India Human Immunodeficiency Virus Therapeutics Market - Competitive Landscape |
10.1 India Human Immunodeficiency Virus Therapeutics Market Revenue Share, By Companies, 2024 |
10.2 India Human Immunodeficiency Virus Therapeutics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here